相关实验视频
Updated: Jan 28, 2026

09:41
Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
Published on: July 19, 2019
12.0K
对非显著初级结果的传播扭曲:多发性硬化症试验中的旋转策略
Marta Mascareñas-García1,2, Alejandro Rivero-de-Aguilar1,3, Cristina Candal-Pedreira1,4,5
1Department of Preventive Medicine and Public Health, Universidade de Santiago de Compostela. Rúa San Francisco s/n, Santiago de Compostela, Spain.
Annals of neurology
|January 26, 2026
概括
在多发性硬化症 (MS) 药物试验中,旋转很普遍,结果不显著,可能会影响临床决策. 这种报告偏差与较小的样本规模和非顶级期刊有关.
科学领域:
- 临床试验 临床试验
- 药学研究 药学研究
- 神经学 神经学
背景情况:
- 旋转,一个强调积极方面或淡化无关紧要发现的报告策略,可能会影响实验治疗的解释.
- 在对多发性硬化症 (MS) 制药的随机对照试验 (RCT) 中评估旋转对于准确的临床决策至关重要.
研究的目的:
- 评估关于MS中药物疗效的RCT中旋转的流行率.
- 确定与这些试验中旋转存在相关的因素.
主要方法:
- 一项系统的文献搜索确定了在2013年至2024年期间发表的第3期和第4期多发性硬化症RCT,其主要结果不显著.
- 在文章的多个部分评估了旋转,包括标题,摘要,结果,讨论和结论.
- 探索性双变物流回归分析了旋转和样本大小,期刊四分位数和作者归属等变量之间的关联.
主要成果:
- 在包括的40件物品中,在62.5%的物品中检测到旋转,其中47.5%的物品呈现出三个或更多部分的旋转.
- 旋转的频繁地点包括抽象的结论,讨论和结论.
- 旋转与较小的样本大小 (OR=7.00),非Q1期刊 (OR=4.38) 和欧洲/美国以外的作者 (OR=5.09) 有关.
结论:
- 旋转是MS RCT报告非显著初级结果的常见问题.
- 旋转的存在可能会在治疗决策中误导临床医生.
- 需要进一步的研究和遵守报告准则,以减轻制药试验报告中的旋转.
相关概念视频
Communication
8.7K
Communication between two animals occurs when one animal transmits an information signal that causes a change in the animal that receives the information. Organisms communicate with one another in a host of different ways. Signals can be auditory, chemical, visual, tactile, or a combination of these. Communication is a critical behavioral adaptation that promotes survival, growth, and reproduction.
8.7K
Communication
9.7K
Sharing information, concepts, and emotions to foster mutual understanding is communication. The sender, recipient, and transaction must be considered in this manner. The sender is the person who shares the message, the recipient is the person who receives and understands the message, and the transaction is the method used to deliver the message and the variables that affect the communication's context and surroundings. The nurse-client connection is built on therapeutic communication.
9.7K
Spin–Spin Coupling Constant: Overview
1.5K
In bromoethane, the three methyl protons are coupled to the two methylene protons that are three bonds away. In accordance with the n+1 rule, the signal from the methyl protons is split into three peaks with 1:2:1 relative intensities. The methylene protons appear as a quartet, with the relative intensities of 1:3:3:1.
Qualitatively, any spin plus-half nucleus polarizes the spins of its electrons to the minus-half state. Consequently, the paired electron in the hydrogen–carbon bond must...
Qualitatively, any spin plus-half nucleus polarizes the spins of its electrons to the minus-half state. Consequently, the paired electron in the hydrogen–carbon bond must...
1.5K
NMR Spectroscopy: Spin–Spin Coupling
3.2K
The spin state of an NMR-active nucleus can have a slight effect on its immediate electronic environment. This effect propagates through the intervening bonds and affects the electronic environments of NMR-active nuclei up to three bonds away; occasionally, even farther. This phenomenon is called spin–spin coupling or J-coupling. Coupling interactions are mutual and result in small changes in the absorption frequencies of both nuclei involved. While nuclei of the same element are involved...
3.2K
Spin–Spin Coupling: One-Bond Coupling
1.5K
Coupling interactions are strongest between NMR-active nuclei bonded to each other, where spin information can be transmitted directly through the pair of bonding electrons. While nuclei polarize their electrons to the opposite spins, the bonding electron pair has opposite spins. Configurations with antiparallel nuclear spins are expected to be lower in energy. When coupling makes antiparallel states more favorable, J is considered to have a positive value. The one-bond coupling constant, 1J,...
1.5K
Clinical Trials: Overview
4.9K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.9K

